We always think of our customers with an open mind
Press Release
NTL Unveils New Product 'CerviCARE® AI', “Leading Artificial Intelligence-Driven Cervical Cancer Diagnosis”
Author
엔티엘헬스케어
Date
2023-05-31 11:49
Views
396
NTL Unveils New Product 'CerviCARE® AI', “Leading Artificial Intelligence-Driven Cervical Cancer Diagnosis”
NTL, Korean obstetrics and gynecology specialized company, participated in the Korean Society of Obstetrics and Gynecology's Spring Academic Conference and unveiled a new product.
On the 2nd, NTL Healthcare (CEO Tae-hee Kim) participated in the '49th Korean Society of Obstetrics and Gynecology Spring Academic Conference' held at Lotte Hotel Seoul in Jung-gu, Seoul, and on the 9th, participated in the '15th Korean Society of Obstetrics and Gynecology (direct election) Spring Academic Conference' held at the Swiss Grand Hotel in Seodaemun-gu, Seoul, unveiling ▲ CerviCARE® AI, an Artificial Intelligence (AI) image reading system, and ▲ PRP injection for improving sexual dysfunction and urinary incontinence.
CerviCARE® AI is a reading system that can confirm cervical cancer test results in less than 5 seconds (1) during outpatient visits. Based on big data accumulated by NTL for 27 years, it shows a high sensitivity. If an abnormality is found based on AI, it can be consulted by requesting reading to gynecologic cancer specialist at university hospitals. In December of last year, it was approved for a Class 3 software for gynecologic medical treatment from the Ministry of Food and Drug Safety.
In addition, CerviCARE® AI is currently undergoing approval procedures from the Thailand Food and Drug Administration (TFDA) following Brazil, and is preparing for global services in Vietnam and African countries including Congo.
Tae-hee Kim, CEO of NTL Healthcare said, "AI cervical cancer reading system is a system that allows women to receive safe and convenient cervical cancer screening, regardless of borders and regions. In addition to CerviCARE® AI, we plan to introduce various platforms focused on obstetrics and gynecology and women's diseases.
NTL is planning to promote its AI image reading system, 'CerviCARE® AI,' at the Korean Society of Obstetrics and Gynecology and Korean Society of Obstetrics and Gynecology (direct election), followed by the Korean Society of Gynecologic Oncology and the Korean Society of Sexual Medicine’s Spring Academic Conference at the end of this month.
Ref: 1) Test Report, Standard Bank, 2023
NTL, Korean obstetrics and gynecology specialized company, participated in the Korean Society of Obstetrics and Gynecology's Spring Academic Conference and unveiled a new product.
On the 2nd, NTL Healthcare (CEO Tae-hee Kim) participated in the '49th Korean Society of Obstetrics and Gynecology Spring Academic Conference' held at Lotte Hotel Seoul in Jung-gu, Seoul, and on the 9th, participated in the '15th Korean Society of Obstetrics and Gynecology (direct election) Spring Academic Conference' held at the Swiss Grand Hotel in Seodaemun-gu, Seoul, unveiling ▲ CerviCARE® AI, an Artificial Intelligence (AI) image reading system, and ▲ PRP injection for improving sexual dysfunction and urinary incontinence.
CerviCARE® AI is a reading system that can confirm cervical cancer test results in less than 5 seconds (1) during outpatient visits. Based on big data accumulated by NTL for 27 years, it shows a high sensitivity. If an abnormality is found based on AI, it can be consulted by requesting reading to gynecologic cancer specialist at university hospitals. In December of last year, it was approved for a Class 3 software for gynecologic medical treatment from the Ministry of Food and Drug Safety.
In addition, CerviCARE® AI is currently undergoing approval procedures from the Thailand Food and Drug Administration (TFDA) following Brazil, and is preparing for global services in Vietnam and African countries including Congo.
Tae-hee Kim, CEO of NTL Healthcare said, "AI cervical cancer reading system is a system that allows women to receive safe and convenient cervical cancer screening, regardless of borders and regions. In addition to CerviCARE® AI, we plan to introduce various platforms focused on obstetrics and gynecology and women's diseases.
NTL is planning to promote its AI image reading system, 'CerviCARE® AI,' at the Korean Society of Obstetrics and Gynecology and Korean Society of Obstetrics and Gynecology (direct election), followed by the Korean Society of Gynecologic Oncology and the Korean Society of Sexual Medicine’s Spring Academic Conference at the end of this month.
Ref: 1) Test Report, Standard Bank, 2023
